Soros Fund Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-500,000
Closed -$5.02M 236
2022
Q4
$5.02M Hold
500,000
0.07% 152
2022
Q3
$4.91M Hold
500,000
0.08% 120
2022
Q2
$4.89M Hold
500,000
0.09% 120
2022
Q1
$4.88M Hold
500,000
0.07% 121
2021
Q4
$4.88M Hold
500,000
0.07% 111
2021
Q3
$4.85M Hold
500,000
0.09% 106
2021
Q2
$4.87M Buy
+500,000
New +$4.89M 0.08% 119

Other funds holding AONC

Soros Fund Management's AONC Position: Q1 2023 in Review

Soros Fund Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 500,000 shares — an estimated $5.02M sold.

Soros Fund Management first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $5.02M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Soros Fund Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Soros Fund Management sold 500,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $5.02M.
  • Soros Fund Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Soros Fund Management's American Oncology Network, Inc. Class A Common Stock position peaked at $5.02M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Soros Fund Management's 13F filing for Q1 2023, filed 12 May 2023.